Department of Community Medicine, College of Medicine, Zaria, Nigeria.
College of Health Sciences and School of Public Health, University of Port Harcourt, Minna, Nigeria.
Niger J Clin Pract. 2023 Jun;26(6):825-831. doi: 10.4103/njcp.njcp_734_22.
Specific death due to DR-TB has significantly contributed to tuberculosis (TB) mortality and overall global deaths.
This study examines the predictors of mortality among DR-TB patients in Kaduna State, Nigeria.
This was a retrospective longitudinal study of DR-TB mortality carried out among 370 DR-TB patients from the 23 LGAs in Kaduna State. It involves a retrospective review of the MDR-TB records of the patients over a period of 10 years (2012-2021). Demographic and clinical data of all DR-TB patients enrolled in Kaduna State, Nigeria, between April 1, 2012, and March 31, 2021, were used. Survival analysis was performed with SPSS version 25, using Kaplan-Meier and Cox proportional hazard regression modeling, at 5% significance level.
The majority of the patients, 255 (68.9%), were below the age of 40 years, while 53 (14.3%) of the patients died within the study period. Most deaths 26 (49.1%) were associated with HIV co-infection and the disease severity. Results for the Cox proportional model show that there was a significantly lower risk of death when a patient had MDR-TB compared to pre-XDR-TB (adjusted hazard ratio, AHR = 0.34, 95% CI = 0.16-0.72, P = 0.04). Both models show that age, sex, residence, or year of treatment had no significant association with survival or death.
HIV co-infection and DRTB with progression to more resistant and difficult-to-treat strains contributed to higher deaths. There is a need for concerted efforts from all DR-TB stakeholders to control the disease.
由于耐多药结核病(DR-TB)导致的特定死亡,对结核病(TB)死亡率和全球总死亡人数有重大影响。
本研究旨在探讨尼日利亚卡杜纳州耐多药结核病(DR-TB)患者的死亡预测因素。
这是一项针对 370 名耐多药结核病患者的回顾性纵向研究,这些患者来自卡杜纳州的 23 个地方政府区。该研究回顾性分析了这些患者在 10 年期间(2012-2021 年)的耐多药结核病记录。使用了 2012 年 4 月 1 日至 2021 年 3 月 31 日期间在尼日利亚卡杜纳州登记的所有耐多药结核病患者的人口统计学和临床数据。使用 SPSS 版本 25 进行生存分析,采用 Kaplan-Meier 和 Cox 比例风险回归模型,显著性水平为 5%。
大多数患者(255 名,68.9%)年龄在 40 岁以下,而在研究期间有 53 名(14.3%)患者死亡。大多数死亡病例(26 例,49.1%)与 HIV 合并感染和疾病严重程度有关。Cox 比例模型的结果显示,与预广泛耐药结核病(XDR-TB)相比,患者患有耐多药结核病时死亡的风险显著降低(调整后的危险比,AHR = 0.34,95%置信区间,CI = 0.16-0.72,P = 0.04)。两个模型都表明,年龄、性别、居住地或治疗年份与生存或死亡均无显著关联。
HIV 合并感染和耐多药结核病进展为更具耐药性和更难治疗的菌株导致死亡率升高。所有耐多药结核病利益相关者都需要共同努力来控制该疾病。